2. Search Result
Search Result
Results for "

haemoglobin

" in MCE Product Catalog:

9

Inhibitors & Agonists

1

Peptides

1

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas
  • HY-141510
    myo-Inositol trispyrophosphate hexasodium

    ITPP hexasodium

    		 Others Cancer
    myo-Inositol trispyrophosphate (ITPP) hexasodium, a modifier of haemoglobin, is an allosteric effector that reduces the oxygen‐binding affinity of haemoglobin and facilitates the release of oxygen by red blood cells. myo-Inositol trispyrophosphate can reverse hypoxia, control tumor growth and improve chemotherapy response.
  • HY-18681
    Voxelotor
    5+ Cited Publications

    GBT 440

    		 Others Cardiovascular Disease
    Voxelotor (GBT 440) is a potent inhibitor of haemoglobin S (HbS) polymerization. Voxelotor has the potential for sickle cell disease (SCD) treatment.
  • HY-141510A
    myo-Inositol trispyrophosphate hexa-triethylamine

    ITPP hexa-triethylamine

    		 Others Others
    myo-Inositol trispyrophosphate (ITPP) hexa-triethylamine, a inositol tripyrophosphate (ITPP) salt, is a membrane permeant allosteric effector of haemoglobin.
  • HY-13619
    Efaproxiral
    1 Publications Verification

    RSR13

    		 Reactive Oxygen Species Cancer
    Efaproxiral is a haemoglobin (Hb) synthetic allosteric modifier, decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy .
  • HY-148788
    Osivelotor

    GBT-601; GBT-021601

    		 Others Others
    Osivelotor is an allosteric modulator of haemoglobin S (HbS).
  • HY-13619A
    Efaproxiral sodium
    1 Publications Verification

    RSR13 sodium

    		 Reactive Oxygen Species Cancer
    Efaproxiral sodium (RSR13 sodium) is a synthetic allosteric modifier of haemoglobin (Hb), decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy.
  • HY-13619S
    Efaproxiral-d6

    		Reactive Oxygen Species Cancer
    Efaproxiral-d6 is the deuterium labeled Efaproxiral. Efaproxiral (RSR13) is a haemoglobin (Hb) synthetic allosteric modifier, decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy[1][2].
  • HY-114134
    Epoetin beta

    rhEPO; EPOCH; Genetical recombination

    		 Others Cancer Metabolic Disease
    Epoetin beta (rhEPO) is a recombinant form of erythropoietin. Epoetin beta is responsible for the maintenance of erythropoiesis and can be used for anaemia research.
  • HY-101193
    Zinc Protoporphyrin
    Maximum Cited Publications
    21 Publications Verification

    Zn(II)-protoporphyrin IX; ZnPP; Zinc Protoporphyrin-9

    		 Reactive Oxygen Species Endogenous Metabolite Apoptosis Cancer Metabolic Disease Cardiovascular Disease
    Zinc Protoporphyrin (Zn(II)-protoporphyrin IX) is an orally active and competitive heme oxygenase-1 (HO-1) inhibitor and markedly attenuates the protective effects of Phloroglucinol (PG) against H2O2. Zinc Protoporphyrin is used as a screening marker of iron deficiency in individual pregnant women and children, but also to assess population iron status in combination with haemoglobin concentration. Zinc Protoporphyrin has anti-cancer activity.